The ECB is committed to ensuring that cricket is a drug free sport and that the integrity of the performances seen on pitches in England and Wales is protected.
To achieve this, the ECB ensures that all stakeholders understand their rights risks and responsibilities in relation to anti-doping by running a comprehensive player and support personnel education and information programme across its elite men’s and women’s player pathways.
This education programme is underpinned by an intelligence-led, risk-based testing programme, delivered across all ECB competitions and ‘out of competition’ at training or nets. This programme is comprised of the collection and analysis of urine and blood samples and is delivered in collaboration with the UK’s National Anti-Doping Organisation, UK Anti-Doping (UKAD) and the International Cricket Council (ICC).
All of the ECB’s work in this area is consistent and compliant with the World Anti-Doping Code (WADC), the International Standards (IS) and the UK National Anti-Doping Policy (NADP).
The ECB also delivers a welfare based Recreational Drugs testing programme across elite cricket, governed by the Recreational Drugs Policy (RDP). Whilst there are consequences for players who violate the RDP, the programme is designed to identify players with welfare challenges and to provide them with bespoke support in collaboration with the Professional Cricketers Association (PCA).